ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,378 | -30.9% | 450 | -20.6% | 0.00% | – |
| Q2 2023 | $13,580 | +621.6% | 567 | +467.0% | 0.00% | – |
| Q1 2023 | $1,882 | +18.2% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $1,592 | -20.4% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -100.0% | 100 | -99.3% | 0.00% | -100.0% |
| Q1 2021 | $380,292,000 | +4225366.7% | 14,740 | +8322.9% | 0.00% | – |
| Q4 2020 | $9,000 | +28.6% | 175 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | +75.0% | 175 | +133.3% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 75 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -92.9% | 75 | -95.3% | 0.00% | -100.0% |
| Q2 2019 | $42,000 | -22.2% | 1,600 | -38.5% | 0.00% | -33.3% |
| Q3 2018 | $54,000 | -48.6% | 2,600 | -62.3% | 0.00% | -50.0% |
| Q2 2018 | $105,000 | -33.1% | 6,900 | -1.4% | 0.01% | -45.5% |
| Q1 2018 | $157,000 | -21.5% | 7,000 | +5.3% | 0.01% | -26.7% |
| Q4 2017 | $200,000 | – | 6,650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,250,000 | $144,218,000 | 15.05% |
| Baker Brothers Advisors | 19,955,126 | $548,167,000 | 7.79% |
| HARVEY CAPITAL MANAGEMENT INC | 508,000 | $13,954,000 | 7.08% |
| RA Capital Management | 2,035,510 | $55,915,000 | 5.84% |
| Bodri Capital Management, LLC | 150,000 | $4,121,000 | 2.40% |
| Cupps Capital Management, LLC | 920,017 | $25,272,000 | 1.64% |
| Perceptive Advisors | 1,221,230 | $33,548,000 | 1.38% |
| Geduld E E | 80,000 | $2,198,000 | 1.34% |
| Alkeon Capital Management | 1,709,200 | $46,951,000 | 0.92% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,205,651 | $33,119,000 | 0.90% |